PTAB Weighs Obviousness Standard In Gene Therapy Case
The Patent Trial and Appeal Board wrestled Wednesday with Arbutus Biopharma's argument that its rival failed to prove that claims in its patent covering a drug delivery composition are obvious on...To view the full article, register now.
Already a subscriber? Click here to view full article